InflaRx Statistics
Total Valuation
InflaRx has a market cap or net worth of $54.73 million. The enterprise value is -$15.70 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
InflaRx has 67.75 million shares outstanding. The number of shares has increased by 2.67% in one year.
Current Share Class | 67.75M |
Shares Outstanding | 67.75M |
Shares Change (YoY) | +2.67% |
Shares Change (QoQ) | +7.26% |
Owned by Insiders (%) | 6.38% |
Owned by Institutions (%) | 16.29% |
Float | 56.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 390.23 |
Forward PS | 121.80 |
PB Ratio | 0.71 |
P/TBV Ratio | 0.72 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.01.
Current Ratio | 5.28 |
Quick Ratio | 4.17 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,661.73 |
Financial Efficiency
Return on equity (ROE) is -54.13% and return on invested capital (ROIC) is -40.06%.
Return on Equity (ROE) | -54.13% |
Return on Assets (ROA) | -34.47% |
Return on Invested Capital (ROIC) | -40.06% |
Return on Capital Employed (ROCE) | -75.60% |
Revenue Per Employee | $1,895 |
Profits Per Employee | -$653,200 |
Employee Count | 74 |
Asset Turnover | 0.00 |
Inventory Turnover | 0.35 |
Taxes
In the past 12 months, InflaRx has paid $5,639 in taxes.
Income Tax | 5,639 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.51% in the last 52 weeks. The beta is 1.32, so InflaRx's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | -49.51% |
50-Day Moving Average | 1.23 |
200-Day Moving Average | 1.66 |
Relative Strength Index (RSI) | 36.81 |
Average Volume (20 Days) | 372,084 |
Short Selling Information
Short Interest | 1.18M |
Short Previous Month | 1.27M |
Short % of Shares Out | 1.87% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.50 |
Income Statement
In the last 12 months, InflaRx had revenue of $140,242 and -$48.34 million in losses. Loss per share was -$0.81.
Revenue | 140,242 |
Gross Profit | -3.22M |
Operating Income | -57.85M |
Pretax Income | -51.25M |
Net Income | -48.34M |
EBITDA | -57.80M |
EBIT | -57.85M |
Loss Per Share | -$0.81 |
Full Income Statement Balance Sheet
The company has $71.19 million in cash and $759,434 in debt, giving a net cash position of $70.43 million or $1.04 per share.
Cash & Cash Equivalents | 71.19M |
Total Debt | 759,434 |
Net Cash | 70.43M |
Net Cash Per Share | $1.04 |
Equity (Book Value) | 76.16M |
Book Value Per Share | 1.12 |
Working Capital | 75.02M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$51.56 million and capital expenditures -$44,583, giving a free cash flow of -$55.96 million.
Operating Cash Flow | -51.56M |
Capital Expenditures | -44,583 |
Free Cash Flow | -55.96M |
FCF Per Share | -$0.83 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -41,252.05% |
Pretax Margin | -34,462.68% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
InflaRx does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.67% |
Shareholder Yield | -2.67% |
Earnings Yield | -88.32% |
FCF Yield | -102.26% |
Analyst Forecast
The average price target for InflaRx is $7.75, which is 859.40% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $7.75 |
Price Target Difference | 859.40% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 113.14% |
EPS Growth Forecast (5Y) | -12.58% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
InflaRx has an Altman Z-Score of -3.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.11 |
Piotroski F-Score | 1 |